MEDIA
Want to find out what’s happening with us?
Here’s the latest buzz…
February, 2023
Milrinone Lactate Injection - The latest addition to our injectables portfolio
Somerset Pharma is proud to announce yet another addition to its portfolio with the launch of Milrinone Lactate Injection. This product compares to Primacor® by Sanofi-Aventis. Milrinone Lactate is indicated for short-term treatment of acute decompensated heart failure.Milrinone Injection is available in 3 pack sizes of 10 x 10mL, 10 x 20mL and 1 x 50mL Single-Dose Vials, with a concentration of 1 mg/mL, and is our fourth product in the cardiac care segment.
At Somerset, we continuously strive to support our healthcare community, in its efforts to deliver high quality and affordable patient care for all.
“With the addition of Milrinone Injection we continue to build on our portfolio making more products available that have seen challenges in availability. We continue to build on our relationships with healthcare professionals like you in the fight against heart disease, and help more patients live longer and healthier lives.”
– Veerappan Subramanian, CEO